Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Generex Biotechnology Corporatio (GNBT)

Generex Biotechnology Corporatio (GNBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 40,116
  • Shares Outstanding, K 71,508
  • Annual Sales, $ 6,200 K
  • Annual Income, $ -9,340 K
  • 60-Month Beta -2.15
  • Price/Sales 7.49
  • Price/Cash Flow N/A
  • Price/Book 8.26
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.56
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/23/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3161 +184.71%
on 02/06/20
1.2000 -25.01%
on 02/27/20
+0.4785 (+113.54%)
since 01/27/20
3-Month
0.1429 +529.93%
on 12/23/19
1.2000 -25.01%
on 02/27/20
+0.6545 (+266.66%)
since 11/27/19
52-Week
0.1257 +615.83%
on 05/31/19
1.2000 -25.01%
on 02/27/20
+0.6370 (+242.35%)
since 02/27/19

Most Recent Stories

More News
Generex Biotechnology Discusses Coronavirus Solutions with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - February 6, 2020) - The Stock Day Podcast welcomed Generex Biotechnology (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end solutions...

GNBT : 1.1000 (+96.08%)
The Comprehensive Study on About Global Advanced Drug Delivery Systems Market 2020 by Growth Factors, Applications, Regional Analysis, Key Players like

BAX : 86.64 (-0.45%)
GNBT : 1.1000 (+96.08%)
MYL : 19.24 (-1.54%)
VRX.TO : 30.80 (-3.33%)
Generex Biotechnology Appoints Independent Directors Craig Eagle, MD and Thomas Leonard to the NuGenerex Immuno-Oncology Board of Directors

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce the appointments of Dr. Craig Eagle, MD and Mr. Thomas Leonard to the...

PFE : 35.48 (+2.19%)
GNBT : 1.1000 (+96.08%)
Generex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of Directors

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce the appointment of Dr. Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology...

GNBT : 1.1000 (+96.08%)
Generex Biotechnology Corporation Discusses Upcoming Revenue Increases and Growth with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - October 7, 2019) - The Stock Day Podcast welcomed Generex Biotechnology Corporation (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end...

GNBT : 1.1000 (+96.08%)
Generex Engages Donohoe Advisory to Assist with Uplisting

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that Generex has engaged Donohoe Advisory Associates LLC ("Donohoe Advisory")...

GNBT : 1.1000 (+96.08%)
The Stock Day Podcast Hosts Generex Biotechnology Corporation to Discuss Uplisting on the NASDAQ

Phoenix, Arizona--(Newsfile Corp. - July 1, 2019) - The Stock Day Podcast welcomed Generex Biotechnology Corporation (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end...

GNBT : 1.1000 (+96.08%)
Generex Announces Update on 1:1 Dividend and NASDAQ Listing

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today provided guidance on the previously announced 1:1 GNBT stock dividend. After discussing...

GNBT : 1.1000 (+96.08%)
Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans

-- Launch of ExcellagenÒ for Wound Healing by subsidiary Olaregen Therapeutix

GNBT : 1.1000 (+96.08%)
Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans

MIRAMAR, Florida , April 29, 2019 /PRNewswire/ --

GNBT : 1.1000 (+96.08%)
MBRX : 0.66 (-4.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Trade GNBT with:

Key Turning Points

2nd Resistance Point 0.7287
1st Resistance Point 0.6448
Last Price 1.1000
1st Support Level 0.5123
2nd Support Level 0.4637

See More

52-Week High 1.2000
Last Price 1.1000
Fibonacci 61.8% 0.7896
Fibonacci 50% 0.6629
Fibonacci 38.2% 0.5361
52-Week Low 0.1257

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar